Gene: PSMB9
Official Full Name: proteasome 20S subunit beta 9provided by HGNC
Gene Summary: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 1 (proteasome beta 6 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. [provided by RefSeq, Mar 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35848 | PSMB9 Knockout cell line (HeLa) | Human | PSMB9 | 1:3~1:6 | Negative | Online Inquiry |
KO35849 | PSMB9 Knockout cell line (HCT 116) | Human | PSMB9 | 1:2~1:4 | Negative | Online Inquiry |
KO35850 | PSMB9 Knockout cell line (A549) | Human | PSMB9 | 1:3~1:4 | Negative | Online Inquiry |
PSMB9 Gene Knockout Cell Lines are a powerful tool in molecular biology, specifically designed for the study of proteasome function and its role in various cellular processes. These cell lines have been genetically engineered to exhibit a targeted knockout of the PSMB9 gene, which encodes for the beta-5 subunit of the immunoproteasome—an essential component of the protein degradation pathway crucial for maintaining cellular homeostasis and immune response modulation.
The primary function of PSMB9 is to facilitate the selective degradation of ubiquitinated proteins, a process vital for regulating cellular processes such as antigen presentation, cell cycle progression, and apoptosis. By disrupting the PSMB9 gene, researchers can elucidate the impact of impaired proteasomal activity on various cellular functions and pathways, making these knockout cell lines invaluable for studying diseases associated with proteasome dysfunction, including cancer, neurodegenerative disorders, and autoimmune diseases.
In both research and clinical settings, PSMB9 knockouts are critical for dissecting the mechanisms underlying immune regulation and developing therapeutic strategies aimed at modulating proteasome activity. Such insights could lead to novel interventions targeting proteasome inhibitors or enhancing their activity, presenting significant implications for cancer immunotherapy.
One of the key advantages of the PSMB9 Gene Knockout Cell Lines is their specificity and reliability; unlike other generic cell lines, these models provide a precise means to investigate the specific roles of PSMB9 in various metabolic and immune pathways. Additionally, they are available in multiple background strains, allowing for the tailoring of experiments to meet the specific needs of the research question at hand.
For researchers and clinicians aiming to deepen their understanding of proteasome biology and explore novel therapeutic avenues, PSMB9 Gene Knockout Cell Lines represent an essential instrument. Our company, renowned for our commitment to advancing cellular and molecular biology tools, offers these cell lines with comprehensive technical support to ensure successful implementation in your studies, reinforcing our position as leaders in providing high-quality biological research products.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.